Showing results (51-60 of 443) with videos related to

Sort By:
Pageof 45
The American Journal of Pathology|June 6, 2018
Strategies to Reduce the Immunogenicity of Recombinant ImmunotoxinsRonit Mazor, Emily M King, Ira Pastan
Oncotarget|April 21, 2017
Paclitaxel synergizes with exposure time adjusted CD22-targeting immunotoxins against B-cell malignanciesFabian Müller, Stephanie Stookey, Tyler Cunningham, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2007
Immunotoxin and Taxol synergy results from a decrease in shed mesothelin levels in the extracellular space of tumorsYujian Zhang, Laiman Xiang, Raffit Hassan, et al.
Cancer Research|May 8, 2012
Antigen shedding may improve efficiencies for delivery of antibody-based anticancer agents in solid tumorsYoungshang Pak, Yujian Zhang, Ira Pastan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2011
Killing of resistant cancer cells with low Bak by a combination of an antimesothelin immunotoxin and a TRAIL Receptor 2 agonist antibodyXing Du, Laiman Xiang, Crystal Mackall, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2003
Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphineTakatoshi Hikida, Yasuji Kitabatake, Ira Pastan, et al.
Clinical Chemistry and Laboratory Medicine|May 10, 2006
Sandwich ELISAs for soluble immunoglobulin superfamily receptor translocation-associated 2 (IRTA2)/FcRH5 (CD307) proteins in human seraTomoko Ise, Robert J Kreitman, Ira Pastan, et al.
Pageof 45